BLOOMBERG – Aug. 5, 2013 – Women who took blood pressure drugs called calcium-channel
blockers, like
Pfizer Inc. (PFE)’s Norvasc, for 10 years or more had a
2.5 times higher risk of developing breast cancer than those who
never took the medicine or who used other blood pressure
treatments, according to research published in
JAMA Internal Medicine. More ...
No comments:
Post a Comment